Medidata Collaborates with gyro New York to Launch New Branding for Clinical Trial Technology Platform

MetaData_Screens.indd

New York [November 10, 2016] – Medidata, the leading global provider of cloud-based solutions and data analytics for clinical research, has selected gyro New York as its creative partner to launch its new brand messaging, the “Architecture of Hope.” The company is collaborating with gyro:human, the agency’s global healthcare practice, to roll out a series of integrated programs that illustrate the important work of the life sciences industry and the pivotal role that Medidata plays in the pursuit of life-changing therapies for patients.

“We’re proud to accelerate hope for our life sciences customers and partners, providing cutting-edge cloud technology and data insights to streamline medical research and deliver better therapies to patients sooner,” said Simon Mouyal, Medidata’s chief marketing officer. “gyro understands the complexity of the healthcare space, and we’re confident that together we will elevate our brand and communicate the value that our unified platform brings to the entire clinical trials ecosystem.”

With 17 years of industry experience in the life sciences vertical, Medidata is driving a transformation in clinical development through its leading cloud technology and sophisticated data analytics capabilities. The Medidata platform has been used by nearly 800 customers around the world—supporting more than 12,000 clinical studies, 420,000 investigational sites and more than 3.1 million trial volunteers. Medidata and gyro worked together to develop and roll out the “Architecture of Hope” messaging to highlight the company’s expertise in study planning, site support, patient engagement, study conduct and study outcome optimization.

“Our healthcare expertise was central to helping us understand not only the solutions themselves, but also the healthcare audiences and the higher purpose that Medidata serves,” added Wendy Lurrie, Managing Director of gyro New York and gyro:human.

The Dentsu Aegis Network recently acquired gyro to create the first fully integrated global B2B powerhouse.

###

About Medidata

Medidata is reinventing global drug development by creating the industry’s leading cloud-based solutions for clinical research. Through our advanced applications and intelligent data analytics, Medidata helps advance the scientific goals of life sciences customers worldwide, including nearly 800 global pharmaceutical companies, innovative biotech, diagnostic and device firms, leading academic medical centers, and contract research organizations.

The Medidata Clinical Cloud® brings a new level of quality and efficiency to clinical trials that empower our customers to make more informed decisions earlier and faster. Our unparalleled clinical trial data assets provide deep insights that pave the way for future growth. The Medidata Clinical Cloud is the primary technology solution powering clinical trials for 17 of the world’s top 25 global pharmaceutical companies, from study design and planning through execution, management and reporting.

About gyro

As a global ideas shop, our mission is to create ideas that are humanly relevant. gyro is Advertising Age’s 2016 B-to-B Agency of the Year and the BMA’s 2016, 2015 and 2014 Global B-to-B Agency of the Year. Our 600 creative minds in 14 offices work with top companies, including Aflac, Danone, eBay, Google, HP, Hewlett Packard Enterprise, Jabra, John Deere, Tate & Lyle, TD Ameritrade, Teva, USG and Vodafone. www.gyro.com